Brief: Lantern Pharma Expands Clinical Leadership Team To Further Advance Its Ongoing And Upcoming Clinical Trials
02/03/2023 13:13
Lantern Pharma Inc LTRN.O :
* LANTERN PHARMA EXPANDS CLINICAL LEADERSHIP TEAM TO FURTHER
ADVANCE ITS ONGOING AND UPCOMING CLINICAL TRIALS
Source text for Eikon: ID:nBw1j1SKya
Further company coverage: LTRN.O
Recent news on Lantern Pharma
See all newsBrief: Lantern Pharma Receives Taiwan Approvals To Open Next Stage Of Phase 2 Harmonic Trial Of Lp-300 In Never-Smoker, Egfr-Mutant Nsclc
Brief: Lantern Pharma Reports Second Quarter 2026 Financial Results And Provides Business Update
Lantern Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Lantern Pharma Q2 operating loss widens on warrant expenses tied to higher stock price
Lantern Pharma Inc expected to post a loss of 38 cents a share - Earnings Preview